Journal
SCHIZOPHRENIA RESEARCH
Volume 202, Issue -, Pages 394-396Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.schres.2018.06.034
Keywords
Glutamate; NMDA receptor; Negative symptoms; Treatment; Ketamine; Psychosis